Member Info for TrickyEFC

Keeping an eye on this one today

Hopefully a sale of an asset and £2million incoming.

As for that UT at 45.20p they having a laugh

Sold a few (£1100) at 46.55p, then went in for a quote on £10k and offered me 46.66p

thats a strong close offering more after a sell.

have a good evening all

Is right Fred.

ps was nt to sell before i left for the shops. those pesky mms

Can we all get a 50? today.

Hi traxpern, that makes 3 of them today. Id say thats filling big orders.

hardly any shares in issue so 1mill volume is big

To get some ice just as well as its hotting up :p

Yes and you can't only via NT

03-Jun-24 13:22:30 45.80 45,209 Unknown* 20.71k

And we have a big buy, will ice man be quiet n freeze now.

Ice man seen ice melt quicker than you been here. 14 may 2024.

Again don't touch but talk trash about this share.

Iceman be cool now

Daffy not sure anyone knows the script here.

Blue now

Been 2 of those this morn

Shown now

Dvharrison you are up n down more than this share price 😁😁

This share is a spastic mentalist.

Anyone have a clue?

Proper strong Monday opening. Any sellers?

The oracle. Hi your post and figures mentioned grabbed my attention. £28pounds per share you say, 3 billion market cap. May Sound like pie in the sky figures,approx a 66 fold increase from current price.

However link below confirms your prediction is no pie in sky.

Out of the 10 listed the biggest leap from previous days close was 95% gain. So it seems that if the news is good one would expect that the majority gains are made in the run up before anyone of us in the public domain will have a clue that a takeover is on the cards.

The main link is at bottom of page but the following example shows that upon First noise of good data Prometheus trebbled in value in two days.

The big prize in the deal is PRA-023 (now MK-7240), a novel candidate in ulcerative colitis (UC), Crohn’s disease and other autoimmune conditions. The monoclonal antibody made waves in December of 2022 with a phase 2 readout that was so impressive that it shot Prometheus’ stock price from $36.06 per share to $117.21 over a two-day span

https://www.fiercepharma.com/special-reports/top-10-biopharma-ma-deals-2023

Hi I think those trades may be buys, hence the reason it went to NT in the run up to those trades.

I could sell all but not able to buy.

Can't be certain but that's my take on it. Buy or sells a 7.4% gain on the day is what we all happy about.